MORGAN STANLEY PLC/PUT/STRYKER CORP./300/0.1/20.06.25 Share Price

Warrant

DE000ME0EXB1

Market Closed - Börse Stuttgart 11:47:05 28/06/2024 pm IST
1.17 EUR -3.31% Intraday chart for MORGAN STANLEY PLC/PUT/STRYKER CORP./300/0.1/20.06.25
Current month-6.40%
1 month-4.88%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
28/24/28 1.17 -3.31%
27/24/27 1.21 +0.83%
26/24/26 1.2 -3.23%
25/24/25 1.24 +3.33%
24/24/24 1.2 -1.64%

Delayed Quote Börse Stuttgart

Last update June 28, 2024 at 11:47 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying STRYKER CORPORATION
Issuer Morgan Stanley
WKN ME0EXB
ISINDE000ME0EXB1
Date issued 07/09/2023
Strike 300 $
Maturity 20/06/2025 (356 Days)
Parity 10 : 1
Emission price 3.69
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 5.38
Lowest since issue 0.98
Delta-0.22x
Omega 5.989
Premium15.57x
Gearing26.7x
Moneyness 0.8817
Difference Strike -40.25 $
Difference Strike %-13.42%
Spread 0.04
Spread %3.31%
Theoretical value 1.190
Implied Volatility 25.99 %
Total Loss Probability 70.38 %
Intrinsic value 0.000000
Present value 1.190
Break even 287.26 €
Theta-0.02x
Vega0.09x
Rho-0.06x

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
340.2 USD
Average target price
372.9 USD
Spread / Average Target
+9.61%
Consensus